Primarily used as a key intermediate in the synthesis of Valsartan, an angiotensin II receptor blocker (ARB) for treating hypertension, heart failure, and post-myocardial infarction. This chemical facilitates multi-step processes including hydrolysis, decarboxylation, and coupling reactions to form the active pharmaceutical ingredient (API). Its biphenyl and malonate structure enables precise modifications for high efficacy. Additionally, utilized in R&D for developing novel ARB therapeutics with improved cardiovascular profiles. In industrial settings, it optimizes yields and purity in pharmaceutical production.